Table 2.
Lung HRCT findings vs. hyper‐androgenic finding in 118 patients admitted to hospitals with confirmed COVID‐19 infection
| HRCT findings | N (%) | Hyper‐androgenic findings | N (%) |
|---|---|---|---|
| Number of involved lobes (˃5%) | Both genders (N = 118) | ||
| 0 | 3 (2.5%) | History of acne | 18 (15.3%) |
| 1 | 0 (0.0%) | ||
| 2 | 16 (13.6%) | Current acne | 7 (5.9%) |
| 3 | 21 (17.8%) | Mild | 3 (2.5%) |
| 4 | 31 (26.3%) | Moderate | 4 (3.4%) |
| 5 | 47 (39.8) | Severe | 0 (0.0%) |
| Lobe of lesion distribution (˃5%) | History of greasy skin | 38 (32.2%) | |
| Left upper lobe | 90 (76.2%) | ||
| Left lower lobe | 105 (8.9%) | ||
| Right upper lobe | 78 (66.1%) | Current greasy skin | 23 (19.5%) |
| Right middle lobe | 72 (61.0%) | ||
| Right lower lobe | 109 (92.3%) | History of seborrheic dermatitis | 20 (16.9%) |
| Bilateral upper lobes | 70 (59.3%) | ||
| Bilateral lower lobes | 99 (83.9%) | ||
| Pattern of the lesion | Current seborrheic dermatitis | 6 (5.1%) | |
| Ground glass opacification | 30 (25.4%) | Male (N = 61) | |
| Consolidation | 2 (1.7%) |
Androgenic alopecia (Hamilton‐Norwood scale) |
45 (73.7%) |
| Crazy paving | 1 (0.8%) | Mild | 10 (22.2%) |
| Ground glass and Consolidation | 65 (55.1%) | Moderate | 22 (48.8%) |
| All the three patterns | 20 (16.9%) | Severe | 13 (28.8%) |
| Excess hair | 24 (39.3%) | ||
| Face | 21 (87.5%) | ||
| Ear | 23 (95.8%) | ||
| Chest | 6 (25.0%) | ||
| Pleural effusion | 21 (17.8%) | Pre‐puberty | 0 (0.0%) |
| Pericardial effusion | 1 (0.8%) | Female (N = 57) | |
| Cavitation | 0 (0.0%) |
Androgenic alopecia (Ludwig scale) |
32 (56.1%) |
| Mild | 16 (50.0%) | ||
| Moderate | 14 (43.7%) | ||
| Severe | 2 (6.2%) | ||
| History of infertility | 2 (3.5%) | ||
| Dysmenorrhea | 11 (19.3%) | ||
| History of hirsutism | 15 (26.3%) | ||
| Current hirsutism | 19 (33.3%) | ||
| Face | 17 (89.4%) | ||
| Nipple | 9 (47.3%) | ||